142 related articles for article (PubMed ID: 23621013)
1. Inhibitory effect of neuropilin-1 monoclonal antibody (NRP-1 MAb) on glioma tumor in mice.
Chen L; Miao W; Tang X; Zhang H; Wang S; Luo F; Yan J
J Biomed Nanotechnol; 2013 Apr; 9(4):551-8. PubMed ID: 23621013
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of a monoclonal antibody targeting neuropilin-1 on adhesion of glioma cells to fibronectin.
Chen L; Miao W; Zhang H; Zeng F; Cao C; Qiu R; Yang J; Luo F; Yan J; Lv H; Xu Q
J Biomed Nanotechnol; 2014 Nov; 10(11):3373-80. PubMed ID: 26000395
[TBL] [Abstract][Full Text] [Related]
3. The expression and significance of neuropilin-1 (NRP-1) on glioma cell lines and glioma tissues.
Chen L; Miao W; Tang X; Zhang H; Wang S; Luo F; Yan J
J Biomed Nanotechnol; 2013 Apr; 9(4):559-63. PubMed ID: 23621014
[TBL] [Abstract][Full Text] [Related]
4. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
5. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
6. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
[TBL] [Abstract][Full Text] [Related]
7. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells.
Wang N; Han Y; Luo L; Zhang Q; Ning B; Fang Y
Biomed Pharmacother; 2018 Oct; 106():655-664. PubMed ID: 29990855
[TBL] [Abstract][Full Text] [Related]
8. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
9. A new molecular probe: An NRP-1 targeting probe for the grading diagnosis of glioma in nude mice.
Wu W; Zhong S; Gong Y; Shan Y; Yuan L; Wang L; Chen J; Zhang Z
Neurosci Lett; 2020 Jan; 714():134617. PubMed ID: 31705924
[TBL] [Abstract][Full Text] [Related]
10. [The anti-cancer effect of ZR30 protein via targeting extracellular signal proteins of different cell subpopulations of glioma].
Li YY; Chen XH; Sun T; Hu Y; Zhou YH; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):812-817. PubMed ID: 30481930
[No Abstract] [Full Text] [Related]
11. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.
Sun H; Zheng X; Zhou Y; Zhu W; Ou Y; Shu M; Gao X; Leng T; Qiu P; Yan G
Steroids; 2013 Oct; 78(10):1041-5. PubMed ID: 23831782
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway.
Zeng F; Luo F; Lv S; Zhang H; Cao C; Chen X; Wang S; Li Z; Wang X; Dou X; Dai Y; He M; Zhang Y; Lv H; Yan J; Chen Y
Anticancer Drugs; 2014 Jul; 25(6):663-72. PubMed ID: 24583771
[TBL] [Abstract][Full Text] [Related]
13. Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody.
Ma C; Dou X; Yan J; Wang S; Yang R; Su F; Zhang H; Su X
Anticancer Agents Med Chem; 2019; 19(18):2269-2275. PubMed ID: 31692439
[TBL] [Abstract][Full Text] [Related]
14. RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis.
Li X; Tang T; Lu X; Zhou H; Huang Y
Mol Med Rep; 2011; 4(6):1261-6. PubMed ID: 21842123
[TBL] [Abstract][Full Text] [Related]
15. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
[No Abstract] [Full Text] [Related]
16. Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation.
Ding Y; Zhou J; Wang S; Li Y; Mi Y; Gao S; Xu Y; Chen Y; Yan J
Exp Ther Med; 2018 Aug; 16(2):537-546. PubMed ID: 30116312
[TBL] [Abstract][Full Text] [Related]
17. A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.
Lu L; Chen H; Wang L; Zhao L; Cheng Y; Wang A; Wang F; Zhang X
Int J Nanomedicine; 2020; 15():8875-8892. PubMed ID: 33209022
[TBL] [Abstract][Full Text] [Related]
18. The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
Atzori MG; Tentori L; Ruffini F; Ceci C; Bonanno E; Scimeca M; Lacal PM; Graziani G
J Pharmacol Exp Ther; 2018 Jan; 364(1):77-86. PubMed ID: 29025978
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.
Zhang G; Chen L; Sun K; Khan AA; Yan J; Liu H; Lu A; Gu N
Tumour Biol; 2016 Oct; 37(10):13777-13788. PubMed ID: 27481513
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
